Clinical utility of serum procalcitonin in adult patients admitted with community-acquired pneumonia in Ilorin, Nigeria
Open Access
- 25 May 2021
- journal article
- research article
- Published by Scientific Scholar in Journal of the Pan African Thoracic Society
- Vol. 2, 77-84
Abstract
Objectives: The usefulness of biomarkers in community acquired pneumonia (CAP) has been under the research light with limited reports from Africa. This study aimed at evaluating the clinical usefulness of serum procalcitonin (PCT) in patients admitted with CAP in a tertiary hospital in Ilorin, Nigeria. Materials and Methods: This was prospective single center observational study of 102 admitted patients with clinical and radiologic features of CAP. All the patients had serum PCT assay, complete blood count, blood culture, sputum microbiology, and serological evaluation for atypical pathogens. Repeat PCT assay was done following 1 week of antibiotic therapy. The patients were classified into one of two diagnostic groups: Those with microbiologically confirmed bacterial CAP and those without bacterial CAP. Results: Over half (58/102; 56.8%) of the patients had microbiologically confirmed bacterial CAP. The baseline serum PCT concentrations were significantly higher in patients with bacterial CAP when compared to the non-bacterial CAP group (2.55 ± 0.14 vs. 0.94 ± 0.61 ng/ml; P < 0.001). There was also a statistically significant difference between the pre- and post-treatment serum PCT concentrations in the bacterial CAP group (P < 0.001) and the non-bacterial CAP group (P = 0.006). The area under the receiver operating characteristic (AUC) for pre-treatment PCT in diagnosing bacterial CAP was 0.795 (95% confidence level [CI]: 0.709–0.881) with a sensitivity of 67.2% and specificity of 79.5% at an optimal cutoff of 1.5 ng/ml. Overall, the biomarker was independently associated with white cell counts >10 × 109/L (AOR = 6.28; 95% CI: 1.30–30.32, P = 0.02). The baseline mean serum PCT levels were also significantly higher in patients admitted for 7 or more days (P = 0.010). Conclusion: Serum PCT had good diagnostic strength in patients admitted with bacterial CAP in Ilorin. The biomarker can also assist clinicians with predicting the pathogenic group and monitoring clinical progress of CAP.Keywords
This publication has 24 references indexed in Scilit:
- The Pattern of Respiratory Disease Morbidity and Mortality in a Tertiary Hospital in Southern-Eastern NigeriaPulmonary Medicine, 2013
- Evaluation of C-reactive protein, procalcitonin, tumor necrosis factor alpha, interleukin-6, and interleukin-8 as diagnostic parameters in sepsis-related fatalitiesInternational journal of legal medicine, 2011
- Admission profile and management of community acquired pneumonia in Nigeria-5 year experience in a tertiary hospitalRespiratory Medicine, 2011
- Procalcitonin Levels Predict Bacteremia in Patients With Community-Acquired PneumoniaChest, 2010
- Respiratory diseases morbidity and mortality among adults attending a tertiary hospital in NigeriaJornal Brasileiro de Pneumologia, 2009
- Procalcitonin for the clinical laboratory: a reviewPathology, 2007
- Procalcitonin Guidance of Antibiotic Therapy in Community-acquired PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Community-acquired pneumonia in the emergency departmentEmergency Medicine Clinics of North America, 2003
- Testing Strategies in the Initial Management of Patients with Community-Acquired PneumoniaAnnals of Internal Medicine, 2003
- Procalcitonin and C-Reactive Protein Levels in Community-Acquired Pneumonia: Correlation with Etiology and PrognosisInfection, 2000